233 related articles for article (PubMed ID: 20080459)
21. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
[No Abstract] [Full Text] [Related]
22. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.
Judkins AR
Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433
[TBL] [Abstract][Full Text] [Related]
23. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
[TBL] [Abstract][Full Text] [Related]
25. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
Kuwahara Y; Wei D; Durand J; Weissman BE
Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
[TBL] [Abstract][Full Text] [Related]
26. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
Al-Hussaini M; Hirschowitz L; McCluggage WG
Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
[TBL] [Abstract][Full Text] [Related]
27. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome.
Lee HY; Yoon CS; Sevenet N; Rajalingam V; Delattre O; Walford NQ
Pediatr Dev Pathol; 2002; 5(4):395-9. PubMed ID: 12016529
[TBL] [Abstract][Full Text] [Related]
28. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
29. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
30. Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.
Kerl K; Holsten T; Frühwald MC
Pediatr Hematol Oncol; 2013 Oct; 30(7):587-604. PubMed ID: 23848359
[TBL] [Abstract][Full Text] [Related]
31. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
[TBL] [Abstract][Full Text] [Related]
32. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
33. Two single nucleotide polymorphisms of the hSNF5/INI1 gene.
Mine N; Bando K; Utada Y; Nagai H; Araki T; Emi M
J Hum Genet; 1999; 44(5):354-5. PubMed ID: 10496084
[TBL] [Abstract][Full Text] [Related]
34. [Atypical teratoid/rhabdoid tumors of childhood].
Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
Medjkane S; Novikov E; Versteege I; Delattre O
Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
Bartelheim K; Sumerauer D; Behrends U; Kodetova D; Kucera F; Leuschner I; Neumayer P; Oyen F; Rübe C; Siebert R; Schneppenheim R; Seeringer A; Vasovcak P; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):379-83. PubMed ID: 24972932
[TBL] [Abstract][Full Text] [Related]
37. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
Albanese P; Belin MF; Delattre O
Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
[TBL] [Abstract][Full Text] [Related]
38. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.
Donner LR; Wainwright LM; Zhang F; Biegel JA
Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508
[TBL] [Abstract][Full Text] [Related]
39. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
40. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.
Bourdeaut F; Lequin D; Brugières L; Reynaud S; Dufour C; Doz F; André N; Stephan JL; Pérel Y; Oberlin O; Orbach D; Bergeron C; Rialland X; Fréneaux P; Ranchere D; Figarella-Branger D; Audry G; Puget S; Evans DG; Pinas JC; Capra V; Mosseri V; Coupier I; Gauthier-Villars M; Pierron G; Delattre O
Clin Cancer Res; 2011 Jan; 17(1):31-8. PubMed ID: 21208904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]